7 August 2019
Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the United States District Court for the Southern District of New York on behalf of all investors that purchased Abiomed, Inc. (NASDAQ: AMBD) securities between January 31, 2019 and July 31, 2019 (the “Class Period”). Investors have until October 7, 2019 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
